home login careers contact sitemap help
pharmacom index.htm
Products Analysis Support Technology Corporate
Biopharmaceutical
Target Identification
Preclinical Studies
Clinical Trials
Regulatory Affairs
Biotechnology
DNA-based biosensors
RNA-based biosensors
Protein-based biosensors
Immuno biosensors
Cell-based biosensors
Microbial biosensors
Optic biosensors
Electronic biosensors
Nano-scaled biosensors
Biodefense
Therapeutics
Vaccines
Adjuvants/Immuostimulants
Diagnostics
Prevention
Bioinformatics
Genomics
Proteomics
Functional Genomics
Structural Genomics

Biosensors may be used in conjunction with enzyme-linked immunosorbent assays (ELISA). ELISA is used to detect and amplify an antigen-antibody reaction; the amount of enzyme-linked antigen bound to the immobilised antibody being determined by the relative concentration of the free and conjugated antigen and quantified by the rate of enzymic reaction. Enzymes with high turnover numbers are used in order to achieve rapid response. The sensitivity of such assays may be further enhanced by utilising enzyme-catalysed reactions which give intrinsically greater response; for instance, those giving rise to highly coloured, fluorescent or bioluminescent products. Assay kits using this technique are now available for a vast range of analyses.

Principles of a direct competitive ELISA

Resources
Glossary of Immunology
Pharmacom Copyright 1997-2003 Feedback